OFS
UTHR icon

Orrstown Financial Services’s United Therapeutics UTHR Stock Holding History

Orrstown Financial Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20
Closed -$2K – 205
2019
Q3 		$2K Hold
20
– – ﹤0.01% 219
2019
Q2 		$2K Hold
20
– – ﹤0.01% 211
2019
Q1 		$2K Sell
20
-20
-50% -$2.33K ﹤0.01% 215
2018
Q4 		$4K Hold
40
– – 0.01% 194
2018
Q3 		$5K Hold
40
– – 0.01% 197
2018
Q2 		$5K Sell
40
-31
-44% -$3.41K 0.01% 238
2018
Q1 		$8K Buy
71
+31
+78% +$3.94K 0.01% 236
2017
Q4 		$6K Sell
40
-55
-58% -$6.99K 0.01% 255
2017
Q3 		$11K Buy
95
+55
+138% +$7.02K 0.01% 227
2017
Q2 		$5K Buy
40
+10
+33% +$1.25K 0.01% 240
2017
Q1 		$4K Hold
30
– – ﹤0.01% 240
2016
Q4 		$4K Hold
30
– – ﹤0.01% 234
2016
Q3 		$4K Buy
30
+20
+200% +$2.4K ﹤0.01% 231
2016
Q2 		$1K Buy
+10
New +$1.11K ﹤0.01% 273

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Orrstown Financial Services's UTHR Position: Q4 2019 in Review

Orrstown Financial Services sold out of United Therapeutics (UTHR) in Q4 2019, closing a stake of 20 shares — an estimated $2K sold.

Orrstown Financial Services first reported a position in UTHR in Q2 2016 and held it in 14 quarters. The position peaked at $11K in Q3 2017. 320 funds tracked by Wall St. Rank hold UTHR as of Q4 2019.

  • Orrstown Financial Services reported no remaining United Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Orrstown Financial Services sold 20 United Therapeutics shares in Q4 2019, an estimated $2K.
  • Orrstown Financial Services first reported a position in United Therapeutics in Q2 2016 and held it in 14 quarters.
  • Orrstown Financial Services's United Therapeutics position peaked at $11K in Q3 2017.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2019.

Based on Orrstown Financial Services's 13F filing for Q4 2019, filed 17 Jan 2020.